Literature DB >> 10910803

Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder.

M Zimmerman1, W McDermut, J I Mattia.   

Abstract

OBJECTIVE: The authors determined the frequency of anxiety disorders in a large group of depressed outpatients seeking treatment.
METHOD: The Structured Clinical Interview for DSM-IV was administered to 373 depressed outpatients.
RESULTS: More than one-half of the patients met the full criteria for a current anxiety disorder, and more than one-half of the patients with an anxiety disorder had more than one. When partial remissions and anxiety disorder diagnoses classified as "not otherwise specified" were included, two-thirds of the patients had a current anxiety disorder and three-quarters had a lifetime history of an anxiety disorder.
CONCLUSIONS: The majority of patients with a principal diagnosis of unipolar major depressive disorder have a comorbid anxiety disorder. Because antidepressant medications have differential efficacies for anxiety disorders, knowledge of the presence of a comorbid anxiety disorder in a depressed patient may have treatment implications.

Entities:  

Mesh:

Year:  2000        PMID: 10910803     DOI: 10.1176/appi.ajp.157.8.1337

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  31 in total

1.  High anxiety is associated with an increased risk of death in an older tri-ethnic population.

Authors:  Glenn V Ostir; James S Goodwin
Journal:  J Clin Epidemiol       Date:  2006-01-23       Impact factor: 6.437

2.  Managing depression in primary care: achieving remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

3.  Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder.

Authors:  Lisa R Steenkamp; Christina M Hough; Victor I Reus; Felipe A Jain; Elissa S Epel; S Jill James; Alexandra E Morford; Synthia H Mellon; Owen M Wolkowitz; Daniel Lindqvist
Journal:  J Affect Disord       Date:  2017-05-06       Impact factor: 4.839

4.  Comorbid anxiety moderates the relationship between depression history and prefrontal EEG asymmetry.

Authors:  Robin Nusslock; Alexander J Shackman; Brenton W McMenamin; Lawrence L Greischar; Richard J Davidson; Maria Kovacs
Journal:  Psychophysiology       Date:  2017-07-29       Impact factor: 4.016

5.  The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment.

Authors:  Joanna M Berg; Jamie C Kennedy; Boadie W Dunlop; Cynthia L Ramirez; Lindsay M Stewart; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  Pers Med Psychiatry       Date:  2017-01-05

6.  Effect of age on the frequency of anxiety disorders in major depression with psychotic features.

Authors:  Alastair J Flint; Catherine Peasley-Miklus; Eros Papademetriou; Barnett S Meyers; Benoit H Mulsant; Anthony J Rothschild; Ellen M Whyte
Journal:  Am J Geriatr Psychiatry       Date:  2010-05       Impact factor: 4.105

Review 7.  Anxious depression: clinical features and treatment.

Authors:  Sanjai Rao; Sidney Zisook
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

8.  Generalized anxiety disorder severity scale validation in older adults.

Authors:  Carmen Andreescu; Bea Herbeck Belnap; Bruce L Rollman; Patricia Houck; Caroline Ciliberti; Sati Mazumdar; M Katherine Shear; Eric J Lenze
Journal:  Am J Geriatr Psychiatry       Date:  2008-10       Impact factor: 4.105

9.  Mental disorders and mental health care in Canada and Australia: comparative epidemiological findings.

Authors:  Raymond Tempier; Graham N Meadows; Helen-Maria Vasiliadis; Karen E Mosier; Alain Lesage; Anna Stiller; Annette Graham; Marje Lepnurm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-14       Impact factor: 4.328

Review 10.  Don't worry; be informed about the epigenetics of anxiety.

Authors:  Steven J Nieto; Michelle A Patriquin; David A Nielsen; Therese A Kosten
Journal:  Pharmacol Biochem Behav       Date:  2016-05-14       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.